Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Combined Analysis of Metabolomes, Proteomes, and Transcriptomes of Hepatitis C Virus-Infected Cells and Liver to Identify Pathways Associated With Disease Development.

Lupberger J, Croonenborghs T, Roca Suarez AA, Van Renne N, Jühling F, Oudot MA, Virzì A, Bandiera S, Jamey C, Meszaros G, Brumaru D, Mukherji A, Durand SC, Heydmann L, Verrier ER, El Saghire H, Hamdane N, Bartenschlager R, Fereshetian S, Ramberger E, Sinha R, Nabian M, Everaert C, Jovanovic M, Mertins P, Carr SA, Chayama K, Dali-Youcef N, Ricci R, Bardeesy NM, Fujiwara N, Gevaert O, Zeisel MB, Hoshida Y, Pochet N, Baumert TF.

Gastroenterology. 2019 Apr 9. pii: S0016-5085(19)35670-7. doi: 10.1053/j.gastro.2019.04.003. [Epub ahead of print]

PMID:
30978357
2.

HCV-Induced Epigenetic Changes Associated With Liver Cancer Risk Persist After Sustained Virologic Response.

Hamdane N, Jühling F, Crouchet E, El Saghire H, Thumann C, Oudot MA, Bandiera S, Saviano A, Ponsolles C, Roca Suarez AA, Li S, Fujiwara N, Ono A, Davidson I, Bardeesy N, Schmidl C, Bock C, Schuster C, Lupberger J, Habersetzer F, Doffoël M, Piardi T, Sommacale D, Imamura M, Uchida T, Ohdan H, Aikata H, Chayama K, Boldanova T, Pessaux P, Fuchs BC, Hoshida Y, Zeisel MB, Duong FHT, Baumert TF.

Gastroenterology. 2019 Jun;156(8):2313-2329.e7. doi: 10.1053/j.gastro.2019.02.038. Epub 2019 Mar 2.

3.

Oncogenic Signaling Induced by HCV Infection.

Virzì A, Roca Suarez AA, Baumert TF, Lupberger J.

Viruses. 2018 Oct 2;10(10). pii: E538. doi: 10.3390/v10100538. Review.

4.

Beyond viral dependence: The pathological consequences of HCV-induced EGF signaling.

Roca Suarez AA, Baumert TF, Lupberger J.

J Hepatol. 2018 Sep;69(3):564-566. doi: 10.1016/j.jhep.2018.05.033. Epub 2018 Jun 22. No abstract available.

PMID:
29937068
5.

Viral manipulation of STAT3: Evade, exploit, and injure.

Roca Suarez AA, Van Renne N, Baumert TF, Lupberger J.

PLoS Pathog. 2018 Mar 15;14(3):e1006839. doi: 10.1371/journal.ppat.1006839. eCollection 2018 Mar. Review.

6.

miR-135a-5p-mediated downregulation of protein tyrosine phosphatase receptor delta is a candidate driver of HCV-associated hepatocarcinogenesis.

Van Renne N, Roca Suarez AA, Duong FHT, Gondeau C, Calabrese D, Fontaine N, Ababsa A, Bandiera S, Croonenborghs T, Pochet N, De Blasi V, Pessaux P, Piardi T, Sommacale D, Ono A, Chayama K, Fujita M, Nakagawa H, Hoshida Y, Zeisel MB, Heim MH, Baumert TF, Lupberger J.

Gut. 2018 May;67(5):953-962. doi: 10.1136/gutjnl-2016-312270. Epub 2017 Feb 3.

7.

Multifaceted role of E-cadherin in hepatitis C virus infection and pathogenesis.

Colpitts CC, Lupberger J, Baumert TF.

Proc Natl Acad Sci U S A. 2016 Jul 5;113(27):7298-300. doi: 10.1073/pnas.1607732113. Epub 2016 Jun 24. No abstract available.

8.

PI4K-beta and MKNK1 are regulators of hepatitis C virus IRES-dependent translation.

Lupberger J, Casanova C, Fischer B, Weiss A, Fofana I, Fontaine N, Fujiwara T, Renaud M, Kopp A, Schuster C, Brino L, Baumert TF, Thoma C.

Sci Rep. 2015 Sep 1;5:13344. doi: 10.1038/srep13344.

9.

Claudins and pathogenesis of viral infection.

Tawar RG, Colpitts CC, Lupberger J, El-Saghire H, Zeisel MB, Baumert TF.

Semin Cell Dev Biol. 2015 Jun;42:39-46. doi: 10.1016/j.semcdb.2015.04.011. Epub 2015 May 7. Review.

PMID:
25960372
10.

Host cell kinases and the hepatitis C virus life cycle.

Colpitts CC, Lupberger J, Doerig C, Baumert TF.

Biochim Biophys Acta. 2015 Oct;1854(10 Pt B):1657-62. doi: 10.1016/j.bbapap.2015.04.011. Epub 2015 Apr 18. Review.

PMID:
25896387
11.

Clearance of persistent hepatitis C virus infection in humanized mice using a claudin-1-targeting monoclonal antibody.

Mailly L, Xiao F, Lupberger J, Wilson GK, Aubert P, Duong FHT, Calabrese D, Leboeuf C, Fofana I, Thumann C, Bandiera S, Lütgehetmann M, Volz T, Davis C, Harris HJ, Mee CJ, Girardi E, Chane-Woon-Ming B, Ericsson M, Fletcher N, Bartenschlager R, Pessaux P, Vercauteren K, Meuleman P, Villa P, Kaderali L, Pfeffer S, Heim MH, Neunlist M, Zeisel MB, Dandri M, McKeating JA, Robinet E, Baumert TF.

Nat Biotechnol. 2015 May;33(5):549-554. doi: 10.1038/nbt.3179. Epub 2015 Mar 23.

12.

CD81-receptor associations--impact for hepatitis C virus entry and antiviral therapies.

Zona L, Tawar RG, Zeisel MB, Xiao F, Schuster C, Lupberger J, Baumert TF.

Viruses. 2014 Feb 18;6(2):875-92. doi: 10.3390/v6020875. Review.

13.

Identification and characterization of a novel bipartite nuclear localization signal in the hepatitis B virus polymerase.

Lupberger J, Schaedler S, Peiran A, Hildt E.

World J Gastroenterol. 2013 Nov 28;19(44):8000-10. doi: 10.3748/wjg.v19.i44.8000.

14.

Functional analysis of claudin-6 and claudin-9 as entry factors for hepatitis C virus infection of human hepatocytes by using monoclonal antibodies.

Fofana I, Zona L, Thumann C, Heydmann L, Durand SC, Lupberger J, Blum HE, Pessaux P, Gondeau C, Reynolds GM, McKeating JA, Grunert F, Thompson J, Zeisel MB, Baumert TF.

J Virol. 2013 Sep;87(18):10405-10. doi: 10.1128/JVI.01691-13. Epub 2013 Jul 17.

15.

Interferon-lambda polymorphisms and hepatitis C virus clearance revisited.

Lupberger J, Felmlee DJ, Baumert TF.

Hepatology. 2013 Jul;58(1):439-41. doi: 10.1002/hep.26443. Epub 2013 May 17. No abstract available.

PMID:
23564545
16.

Epidermal growth factor receptor signaling impairs the antiviral activity of interferon-alpha.

Lupberger J, Duong FH, Fofana I, Zona L, Xiao F, Thumann C, Durand SC, Pessaux P, Zeisel MB, Heim MH, Baumert TF.

Hepatology. 2013 Oct;58(4):1225-35. doi: 10.1002/hep.26404. Epub 2013 Sep 5.

PMID:
23519785
17.

HRas signal transduction promotes hepatitis C virus cell entry by triggering assembly of the host tetraspanin receptor complex.

Zona L, Lupberger J, Sidahmed-Adrar N, Thumann C, Harris HJ, Barnes A, Florentin J, Tawar RG, Xiao F, Turek M, Durand SC, Duong FH, Heim MH, Cosset FL, Hirsch I, Samuel D, Brino L, Zeisel MB, Le Naour F, McKeating JA, Baumert TF.

Cell Host Microbe. 2013 Mar 13;13(3):302-13. doi: 10.1016/j.chom.2013.02.006.

18.

Host-targeting agents for prevention and treatment of chronic hepatitis C - perspectives and challenges.

Zeisel MB, Lupberger J, Fofana I, Baumert TF.

J Hepatol. 2013 Feb;58(2):375-84. doi: 10.1016/j.jhep.2012.09.022. Epub 2012 Oct 4. Review.

19.

Cholesterol uptake and hepatitis C virus entry.

Lupberger J, Felmlee DJ, Baumert TF.

J Hepatol. 2012 Jul;57(1):215-7. doi: 10.1016/j.jhep.2012.02.008. Epub 2012 Mar 2. No abstract available.

20.

[Open Sesame: regulation of hepatitis C virus entry into hepatocytes].

Turek M, Lupberger J, Baumert TF, Zeisel MB.

Med Sci (Paris). 2011 Nov;27(11):929-31. doi: 10.1051/medsci/20112711005. Epub 2011 Nov 30. French. No abstract available.

21.

EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy.

Lupberger J, Zeisel MB, Xiao F, Thumann C, Fofana I, Zona L, Davis C, Mee CJ, Turek M, Gorke S, Royer C, Fischer B, Zahid MN, Lavillette D, Fresquet J, Cosset FL, Rothenberg SM, Pietschmann T, Patel AH, Pessaux P, Doffoël M, Raffelsberger W, Poch O, McKeating JA, Brino L, Baumert TF.

Nat Med. 2011 May;17(5):589-95. doi: 10.1038/nm.2341. Epub 2011 Apr 24.

22.

Apolipoprotein E interacts with hepatitis C virus nonstructural protein 5A and determines assembly of infectious particles.

Benga WJ, Krieger SE, Dimitrova M, Zeisel MB, Parnot M, Lupberger J, Hildt E, Luo G, McLauchlan J, Baumert TF, Schuster C.

Hepatology. 2010 Jan;51(1):43-53. doi: 10.1002/hep.23278.

23.

RNAi: a powerful tool to unravel hepatitis C virus-host interactions within the infectious life cycle.

Lupberger J, Brino L, Baumert TF.

J Hepatol. 2008 Mar;48(3):523-5. doi: 10.1016/j.jhep.2007.12.007. Epub 2007 Dec 31.

24.

Hepatitis B virus-induced oncogenesis.

Lupberger J, Hildt E.

World J Gastroenterol. 2007 Jan 7;13(1):74-81. Review.

25.
26.

Raf-1 kinase associates with Hepatitis C virus NS5A and regulates viral replication.

Bürckstümmer T, Kriegs M, Lupberger J, Pauli EK, Schmittel S, Hildt E.

FEBS Lett. 2006 Jan 23;580(2):575-80. Epub 2005 Dec 29.

27.

A novel system for efficient gene transfer into primary human hepatocytes via cell-permeable hepatitis B virus-like particle.

Brandenburg B, Stockl L, Gutzeit C, Roos M, Lupberger J, Schwartlander R, Gelderblom H, Sauer IM, Hofschneider PH, Hildt E.

Hepatology. 2005 Dec;42(6):1300-9.

PMID:
16317706
28.

Quantitative RT-PCR of Wilms tumor gene transcripts (WT1) for the molecular monitoring of patients with accelerated phase bcr/abl + CML.

Na IK, Kreuzer KA, Lupberger J, Dörken B, le Coutre P.

Leuk Res. 2005 Mar;29(3):343-5.

PMID:
15661271
29.

Autologous peripheral blood stem cell transplantation of stem cells harvested in imatinib-induced complete cytogenetic remission: an example of in vivo purging in CML.

le Coutre P, Kreuzer KA, Massenkeil G, Baskaynak G, Zschieschang P, Genvresse I, Lupberger J, Mapara M, Dörken B, Arnold R.

Leukemia. 2003 Dec;17(12):2525-6. No abstract available.

PMID:
14562118
30.

Imatinib in Philadelphia chromosome-positive chronic phase CML patients: molecular and cytogenetic response rates and prediction of clinical outcome.

Le Coutre P, Kreuzer KA, Na IK, Schwarz M, Lupberger J, Holdhoff M, Baskaynak G, Gschaidmeier H, Platzbecker U, Ehninger G, Prejzner W, Huhn D, Schmidt CA.

Am J Hematol. 2003 Aug;73(4):249-55.

31.

Ralstonia eutropha H16 encodes two and possibly three intracellular Poly[D-(-)-3-hydroxybutyrate] depolymerase genes.

York GM, Lupberger J, Tian J, Lawrence AG, Stubbe J, Sinskey AJ.

J Bacteriol. 2003 Jul;185(13):3788-94.

32.

Quantitative analysis of beta-actin, beta-2-microglobulin and porphobilinogen deaminase mRNA and their comparison as control transcripts for RT-PCR.

Lupberger J, Kreuzer KA, Baskaynak G, Peters UR, le Coutre P, Schmidt CA.

Mol Cell Probes. 2002 Feb;16(1):25-30.

PMID:
12005444
33.

Determination of alpha-1 acid glycoprotein in patients with Ph+ chronic myeloid leukemia during the first 13 weeks of therapy with STI571.

le Coutre P, Kreuzer KA, Na IK, Lupberger J, Holdhoff M, Appelt C, Schwarz M, Müller C, Gambacorti-Passerini C, Platzbecker U, Bonnet R, Ehninger G, Schmidt CA.

Blood Cells Mol Dis. 2002 Jan-Feb;28(1):75-85.

PMID:
11987244
34.

Fluorescent 5'-exonuclease assay for the absolute quantification of Wilms' tumour gene (WT1) mRNA: implications for monitoring human leukaemias.

Kreuzer KA, Saborowski A, Lupberger J, Appelt C, Na IK, le Coutre P, Schmidt CA.

Br J Haematol. 2001 Aug;114(2):313-8.

PMID:
11529849

Supplemental Content

Loading ...
Support Center